Kwang Dong Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Kwang Dong Pharmaceutical has a total shareholder equity of ₩605.4B and total debt of ₩271.0B, which brings its debt-to-equity ratio to 44.8%. Its total assets and total liabilities are ₩1,135.6B and ₩530.2B respectively. Kwang Dong Pharmaceutical's EBIT is ₩36.4B making its interest coverage ratio 23.3. It has cash and short-term investments of ₩160.9B.
Key information
44.8%
Debt to equity ratio
₩270.97b
Debt
| Interest coverage ratio | 23.3x |
| Cash | ₩160.91b |
| Equity | ₩605.45b |
| Total liabilities | ₩530.15b |
| Total assets | ₩1.14t |
Recent financial health updates
Is Kwang Dong Pharmaceutical (KRX:009290) Using Too Much Debt?
Apr 29
Kwang Dong Pharmaceutical (KRX:009290) Seems To Use Debt Quite Sensibly
Jan 19Recent updates
There Is A Reason Kwang Dong Pharmaceutical Co., Ltd.'s (KRX:009290) Price Is Undemanding
Aug 06Kwang Dong Pharmaceutical's (KRX:009290) Solid Profits Have Weak Fundamentals
Mar 25Kwang Dong Pharmaceutical Co., Ltd.'s (KRX:009290) Price Is Right But Growth Is Lacking
Mar 20Is Kwang Dong Pharmaceutical (KRX:009290) Using Too Much Debt?
Apr 29Is Now The Time To Put Kwang Dong Pharmaceutical (KRX:009290) On Your Watchlist?
Apr 06Did Business Growth Power Kwang Dong Pharmaceutical's (KRX:009290) Share Price Gain of 117%?
Mar 18Is Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Popular Amongst Insiders?
Mar 01Should Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Be Part Of Your Dividend Portfolio?
Feb 14Estimating The Fair Value Of Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
Feb 01Kwang Dong Pharmaceutical (KRX:009290) Seems To Use Debt Quite Sensibly
Jan 19If You Like EPS Growth Then Check Out Kwang Dong Pharmaceutical (KRX:009290) Before It's Too Late
Jan 06Here's What We Like About Kwang Dong Pharmaceutical's (KRX:009290) Upcoming Dividend
Dec 24
Can You Imagine How Kwang Dong Pharmaceutical's (KRX:009290) Shareholders Feel About The 54% Share Price Increase?
Dec 18Is There More To The Story Than Kwang Dong Pharmaceutical's (KRX:009290) Earnings Growth?
Dec 04What Type Of Shareholders Own The Most Number of Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290) Shares?
Nov 21Financial Position Analysis
Short Term Liabilities: A009290's short term assets (₩668.3B) exceed its short term liabilities (₩483.4B).
Long Term Liabilities: A009290's short term assets (₩668.3B) exceed its long term liabilities (₩46.8B).
Debt to Equity History and Analysis
Debt Level: A009290's net debt to equity ratio (18.2%) is considered satisfactory.
Reducing Debt: A009290's debt to equity ratio has increased from 23.7% to 44.8% over the past 5 years.
Debt Coverage: A009290's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: A009290's interest payments on its debt are well covered by EBIT (23.3x coverage).